Skip to content

Early Screen, Systematic Evaluation and Risk Warning of Polyvascular Disease Based on Multi-modality Imaging

Early Screen, Systematic Evaluation and Risk Warning of Polyvascular Disease Based on Multi-modality Imaging

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300074638
Enrollment
Unknown
Registered
2023-08-11
Start date
2023-08-15
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polyvascular Disease

Interventions

Case series:none

Sponsors

Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Task 1: 1. Patients with coronary artery disease (=50% stenosis in any coronary artery on coronary angiography) 2. Age =18 years old 3. Proposed OCT-IVUS integrated imaging system 4. able to provide written informed consent prior to the start of any procedures related to the study. Task 2: 1. patients with coronary artery disease (coronary angiography reveals =50% degree of stenosis in any coronary artery) and patients with stroke or TIA (confirmed by a neurologist) 2. Age = 18 years 3. able to provide written informed consent prior to the start of any procedures related to the study. Task 3 is same as Task 1.

Exclusion criteria

Exclusion criteria: Task 1: 1. severely tortuous/calcified coronary arteries with anticipated difficulty in completing the OCT-IVUS integrated imaging system 2. uncontrolled congestive heart failure or acute left heart failure;plan 3. claustrophobia; 4. left main stem occlusion; 5. proposed coronary artery bypass grafting (CABG); 6. uncontrolled severe ventricular arrhythmia; 7. active bleeding or severe bleeding tendency; 8. acute stroke; 9. patients with hemodynamic instability or unstable cardiac electrical activity (including shock) ; 10. severe renal insufficiency and/or anuria, except in cases where dialysis treatment has been planned; 11. contraindications to the application of contrast media; 12. patients who are severely uncooperative due to psychiatric or serious systemic illness; 13. Patients who, in the opinion of the investigator, are unsuitable for participation in the study. Task 2: 1. patients who are unable to comply with the follow-up schedule; 2. uncontrolled congestive heart failure or acute left heart failure; 3. patients with a life expectancy of less than 6 months; 4. left main stem occlusion; 5. proposed coronary artery bypass grafting (CABG); 6. uncontrolled severe ventricular arrhythmia; 7. active bleeding or severe bleeding tendency; 8. patients with hemodynamic instability or unstable cardiac electrical activity (including shock) ; 9. severe renal insufficiency and/or anuria, except in cases where dialysis treatment has been planned; 10. contraindications to the application of contrast media; 11. patients who are severely uncooperative due to psychiatric or serious systemic illness; 12. patients who, in the opinion of the investigator, are not suitable for participation in the study. Task 3: Same as Task 1

Design outcomes

Primary

MeasureTime frame
Plaque characteristics;MACCE;AVR DCP;Metabolomics/proteomics of EV;

Countries

China

Contacts

Public ContactHaibo JIA

Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University

jhb101180@163.com+86 159 4568 5291

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026